Skip to contentB
Boston Scientific Corp
B
BSXBoston Scientific Corp Source filing unavailable
Q1 2019 · —
Revenue$2.49B$2.49B+4.8% vs Q1 2018 Net Income$424.00M$424.00M+42.3% vs Q1 2018 EPS Diluted$0.30$0.30+42.9% vs Q1 2018 Gross Profit$1,763,000,000+3.3% Operating Income$541,000,000+32.9% Operating Cash Flow$350,000,000
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Boston Scientific Corp · CIK 885725 · Engraved from SEC EDGAR
+81.3%
Free Cash Flowderived$287,000,000+115.8% Margins · derivedGross margin70.7%−1.0 pt vs Q1 2018
Operating margin21.7%+4.6 pt vs Q1 2018
Net margin17.0%+4.5 pt vs Q1 2018